Edwards Lifesciences Comprehensive Income 2010-2024 | EW
Edwards Lifesciences comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- Edwards Lifesciences comprehensive income for the quarter ending September 30, 2024 was $-0.253B, a 0.96% increase year-over-year.
- Edwards Lifesciences comprehensive income for 2023 was $-0.243B, a 4.75% decline from 2022.
- Edwards Lifesciences comprehensive income for 2022 was $-0.255B, a 61.64% increase from 2021.
- Edwards Lifesciences comprehensive income for 2021 was $-0.158B, a 2.11% decline from 2020.
| Edwards Lifesciences Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2023 | $-243 |
| 2022 | $-255 |
| 2021 | $-158 |
| 2020 | $-161 |
| 2019 | $-156 |
| 2018 | $-139 |
| 2017 | $-133 |
| 2016 | $-198 |
| 2015 | $-183 |
| 2014 | $-101 |
| 2013 | $-28 |
| 2012 | $-38 |
| 2011 | $-38 |
| 2010 | $-42 |
| 2009 | $-8 |
| Edwards Lifesciences Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-253 |
| 2024-06-30 | $-220 |
| 2024-03-31 | $-233 |
| 2023-12-31 | $-243 |
| 2023-09-30 | $-250 |
| 2023-06-30 | $-256 |
| 2023-03-31 | $-255 |
| 2022-12-31 | $-255 |
| 2022-09-30 | $-256 |
| 2022-06-30 | $-224 |
| 2022-03-31 | $-187 |
| 2021-12-31 | $-158 |
| 2021-09-30 | $-155 |
| 2021-06-30 | $-160 |
| 2021-03-31 | $-172 |
| 2020-12-31 | $-161 |
| 2020-09-30 | $-158 |
| 2020-06-30 | $-146 |
| 2020-03-31 | $-152 |
| 2019-12-31 | $-156 |
| 2019-09-30 | $-156 |
| 2019-06-30 | $-138 |
| 2019-03-31 | $-141 |
| 2018-12-31 | $-139 |
| 2018-09-30 | $-139 |
| 2018-06-30 | $-151 |
| 2018-03-31 | $-121 |
| 2017-12-31 | $-133 |
| 2017-09-30 | $-143 |
| 2017-06-30 | $-158 |
| 2017-03-31 | $-182 |
| 2016-12-31 | $-198 |
| 2016-09-30 | $-171 |
| 2016-06-30 | $-179 |
| 2016-03-31 | $-173 |
| 2015-12-31 | $-183 |
| 2015-09-30 | $-169 |
| 2015-06-30 | $-147 |
| 2015-03-31 | $-148 |
| 2014-12-31 | $-101 |
| 2014-09-30 | $-71 |
| 2014-06-30 | $-41 |
| 2014-03-31 | $-32 |
| 2013-12-31 | $-28 |
| 2013-09-30 | $-43 |
| 2013-06-30 | $-48 |
| 2013-03-31 | $-52 |
| 2012-12-31 | $-38 |
| 2012-09-30 | $-37 |
| 2012-06-30 | $-51 |
| 2012-03-31 | $-25 |
| 2011-12-31 | $-38 |
| 2011-09-30 | $-23 |
| 2011-06-30 | $-10 |
| 2011-03-31 | $-16 |
| 2010-12-31 | $-42 |
| 2010-09-30 | $-24 |
| 2010-06-30 | $-53 |
| 2010-03-31 | $-25 |
| 2009-12-31 | $-8 |
| 2009-09-30 | $-7 |
| 2009-06-30 | $-24 |
| 2009-03-31 | $-34 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $41.510B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $197.408B | 24.08 |
| Intuitive Surgical (ISRG) | United States | $196.120B | 102.54 |
| Alcon (ALC) | Switzerland | $42.207B | 28.24 |
| IQVIA Holdings (IQV) | United States | $35.864B | 19.76 |
| IDEXX Laboratories (IDXX) | United States | $34.273B | 40.36 |
| DexCom (DXCM) | United States | $29.084B | 43.80 |
| Waters (WAT) | United States | $21.880B | 32.35 |
| STERIS (STE) | Ireland | $21.298B | 24.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.458B | 0.00 |
| Hologic (HOLX) | United States | $18.284B | 19.29 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.898B | 13.24 |
| Sysmex ADR (SSMXY) | Japan | $12.776B | 40.07 |
| Globus Medical (GMED) | United States | $11.562B | 29.28 |
| Penumbra (PEN) | United States | $9.230B | 90.41 |
| Masimo (MASI) | United States | $9.055B | 43.81 |
| Teleflex (TFX) | United States | $8.854B | 14.12 |
| Glaukos (GKOS) | United States | $7.765B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.929B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.558B | 25.83 |
| Veracyte (VCYT) | United States | $3.018B | 90.56 |
| Inari Medical (NARI) | United States | $2.913B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.807B | 16.21 |
| TransMedics (TMDX) | United States | $2.663B | 84.40 |
| Nihon Kohden (NHNKY) | Japan | $2.428B | 18.44 |
| Elekta AB (EKTAY) | Sweden | $2.125B | 17.31 |
| Tandem Diabetes Care (TNDM) | United States | $2.019B | 0.00 |
| RxSight (RXST) | United States | $1.816B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.775B | 9.27 |
| Alphatec Holdings (ATEC) | United States | $1.448B | 0.00 |
| Artivion (AORT) | United States | $1.175B | 77.86 |
| OPKO Health (OPK) | United States | $1.065B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.992B | 0.00 |
| Paragon 28 (FNA) | United States | $0.873B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.828B | 14.08 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.714B | 0.00 |
| IRadimed (IRMD) | United States | $0.675B | 36.46 |
| OrthoPediatrics (KIDS) | United States | $0.641B | 0.00 |
| AxoGen (AXGN) | United States | $0.577B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.548B | 12.91 |
| SiBone (SIBN) | United States | $0.515B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.495B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.485B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 32.40 |
| Tactile Systems Technology (TCMD) | United States | $0.383B | 20.70 |
| CVRx (CVRX) | United States | $0.358B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.315B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.306B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.282B | 0.00 |
| NeuroPace (NPCE) | United States | $0.269B | 0.00 |
| Inogen (INGN) | United States | $0.219B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.190B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.164B | 0.00 |
| Nevro (NVRO) | United States | $0.163B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.150B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.146B | 15.67 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.048B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Neuronetics (STIM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |